ASA-404

vadimezan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASA-404, covering 2015-08-19 to 2015-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma [Phase 2]